Evidence map›Paper›PMID 40775455›Full record

ArticleLeukemia2025

Simultaneous whole-body multi-parametric 2-[

Bastien Jamet, Cyrille Touzeau, Hatem Necib, Éric Frampas, Huajun Sun, Chloe Francois, Nicolas Blin, Thomas Carlier, Aurélien Monnet, Nicoletta Lilli and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bastien JametNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France. bastien.jamet@chu-nantes.fr.ORCID 0000-0002-2145-9182
Cyrille TouzeauNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Hématologie, Nantes, France.ORCID 0000-0003-0275-2575
Hatem NecibNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France.
Éric FrampasNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Radiologie, Nantes, France.
Huajun SunNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France.ORCID 0000-0003-0041-9939
Chloe FrancoisNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France.ORCID 0009-0006-6289-2229
Nicolas BlinNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Hématologie, Nantes, France.
Thomas CarlierNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France.ORCID 0000-0002-6932-7322
Aurélien MonnetNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France.
Nicoletta LilliNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Hématologie, Nantes, France.
Caroline Bodet-MilinNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France.
Philippe MoreauNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Hématologie, Nantes, France.ORCID 0000-0003-1780-8746
Françoise Kraeber-BodereNantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The co-primary aims of this study were to assess the diagnostic and prognostic performance of Whole-body-2-[

Indexed as

Fluorodeoxyglucose F18Magnetic Resonance ImagingPositron-Emission TomographySmoldering Multiple MyelomaWhole Body ImagingAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisProspective StudiesRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.